Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis
Authors
Keywords
Breast cancer, Ferroptosis, Ketamine, KAT5, GPX4, Potential therapeutic strategy
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 585, Issue -, Pages 111-116
Publisher
Elsevier BV
Online
2021-11-13
DOI
10.1016/j.bbrc.2021.11.029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine Inhibits Ovarian Cancer Cell Growth by Regulating the lncRNA-PVT1/EZH2/p57 Axis
- (2021) Tao Li et al. Frontiers in Genetics
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
- (2020) Haiyang Zhang et al. Molecular Cancer
- FosB recruits KAT5 to potentiate the growth and metastasis of papillary thyroid cancer in a DPP4-dependent manner
- (2020) Junwei Du et al. LIFE SCIENCES
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Depletion of TRRAP induces p53‐independent senescence in liver cancer by downregulating mitotic genes
- (2019) Suet‐Yan Kwan et al. HEPATOLOGY
- Ketamine inhibits aerobic glycolysis in colorectal cancer cells by blocking the NMDA receptor‐CaMK II‐c‐Myc pathway
- (2019) Jianjun Hu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Intranasal Ketamine and Its Potential Role in Cancer-Related Pain
- (2018) Vinita Singh et al. PHARMACOTHERAPY
- Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69
- (2018) Xuhui Zhou et al. Cancer Medicine
- Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain
- (2018) Marie T. Fallon et al. JAMA Oncology
- KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC
- (2018) Xi Wei et al. ENDOCRINE-RELATED CANCER
- Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer
- (2018) Daiha Shin et al. FREE RADICAL BIOLOGY AND MEDICINE
- TIP60: an actor in acetylation of H3K4 and tumor development in breast cancer
- (2018) Gaëlle Judes et al. Epigenomics
- RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
- (2018) Xinbing Sui et al. Frontiers in Pharmacology
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
- (2017) Samantha W. Alvarez et al. NATURE
- Targeting cancer using KAT inhibitors to mimic lethal knockouts
- (2016) J. A. L. Brown et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma
- (2016) SIAN CREGAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4 + CD25 + Foxp3 + regulatory T cells in vitro
- (2016) Min Hou et al. JOURNAL OF SURGICAL RESEARCH
- Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells
- (2015) Manuela Malsy et al. BMC Anesthesiology
- Regulation of Ferroptotic Cancer Cell Death by GPX4
- (2014) Wan Seok Yang et al. CELL
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- Histone acetyl transferases as emerging drug targets
- (2009) Frank J. Dekker et al. DRUG DISCOVERY TODAY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started